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ABSTRACT
Objectives Periprosthetic fractures have considerable 
clinical implications for patients and financial implications 
for healthcare systems. This study aims to determine the 
burden of periprosthetic fractures of the lower and upper 
limbs in England and identify any factors associated with 
differences in treatment and outcome.
Design A national, observational study.
Setting England.
Participants All individuals admitted to hospital with 
periprosthetic fractures between 1 April 2015 and 31 
December 2018.
Primary and secondary outcome measures Mortality, 
length of stay, change in rate of admissions.
Methods We analysed Hospital Episode Statistics data 
using the International Classification of Diseases 10th 
Revision code M96.6 (Fracture of bone following insertion 
of orthopaedic implant, joint prosthesis, or bone plate) to 
identify periprosthetic fractures recorded between April 2013 
and December 2018. We determined the demographics, 
procedures performed, mortality rates and discharge 
destinations. Patient characteristics associated with having a 
procedure during the index admission were estimated using 
logistic regression. The annual rate of increase in admissions 
was estimated using Poisson regression.
Results Between 1 April 2015 and 31 December 2018, 
there were 13 565 patients who had 18 888 admissions 
(89.5% emergency) with M96.6 in the primary diagnosis field. 
There was a 13% year- on- year increase in admissions for 
periprosthetic fracture in England during that period. Older 
people, people living in deprived areas and those with heart 
failure or neurological disorders were less likely to receive 
an operation. 14.4% of patients did not return home after 
hospital discharge. The overall inpatient mortality was 4.3% 
and total 30- day mortality was 3.3%.
Conclusions The clinical and operational burden of 
periprosthetic fractures is considerable and increasing 
rapidly. We suggest that the management of people with 
periprosthetic fractures should be undertaken and funded 
in a similar manner to that successfully employed for 
people sustaining hip fractures, using national standards 
and data collection to monitor and improve performance.
INTRODUCTION
Since the successful introduction of total hip 
replacement in the 1960s, joint replacement 
has revolutionised the treatment of severely 
arthritic joints.1 Joint replacement prostheses 
are available for all the major joints of the 
upper and lower limbs. In 2018, approxi-
mately 200 000 arthroplasty procedures were 
recorded in the 16th Annual Report of the 
National Joint Registry (NJR) for England 
and Wales.2 Between the advent of the 
registry, on 1 April 2003, and 31 December 
2018, 2.75 million joint replacement proce-
dures have been recorded. In addition, 28 684 
femoral hemiarthroplasties were performed 
in 2018 for proximal femoral fractures.3 
The increasing life expectancy in the UK,4 
combined with the effects of chronic disease 
and frailty,5 leads to an increased likelihood 
of sustaining a fracture due to osteoporosis 
and an increased incidence of falls. Fractures 
can also occur around joint replacements, 
and these are termed periprosthetic fractures. 
Periprosthetic fractures may require either 
fixation or revision of the implant. Surgery to 
treat such fractures is often complex and/or 
prolonged, requiring specialist input from a 
multidisciplinary team.
There has been no comprehensive assess-
ment of the burden of these injuries on 
the healthcare system in England. The NJR 
collects data on revision arthroplasty and iden-
tifies those performed for periprosthetic frac-
ture. However, fractures treated without the 
need to revise the implant are not recorded 
at present in the NJR. The alternative sources 
Strengths and limitations of this study
 ► This is the first study to use International 
Classification of Diseases 10th Revision code M96.6 
to identify trends in periprosthetic fracture rates.
 ► These data can be used to help develop specific 
management pathways and allocate resources.
 ► Use of Hospital Episode Statistics data is limited by 
potential inaccuracies in coding.
 ► The study data do not include functional outcomes, 
which would provide useful information.
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of data are the UK’s four national hospital administrative 
databases: Hospital Episode Statistics (HES) for England 
and similar systems for each of the other three coun-
tries. Clinical coders use International Classification of 
Diseases 10th Revision (ICD-10) and UK- specific Office of 
Population Censuses and Surveys (OPCS) coding systems 
to record diagnosis and procedure information, respec-
tively. Owing to the complex classification of fractures and 
different techniques to treat them, there are many oper-
ative codes that could be used. In March 2015, National 
Health Service (NHS) England issued new guidance to 
clinical coders regarding periprosthetic fractures.6 The 
new ICD-10 code M96.6 (‘Fracture of bone following 
insertion of orthopaedic implant, joint prosthesis, or 
bone plate’) is designed to capture all patients who have 
experienced a periprosthetic fracture at any time during 
an episode of care, regardless of site or operative treat-
ment. It also captures fractures around fixation devices 
such as plates and intramedullary nails.
The purpose of this observational study is to quan-
tify the burden of these cases on the NHS and identify 
any trends in the treatment of these conditions, which 
may inform future healthcare resource planning. Using 
England’s national hospital administrative database, HES, 
we describe the admissions with the new M96.6 diagnosis 
code, time trends, patient characteristics, operative rate 
and short- term outcomes. A literature review carried out 
by the authors did not identify any previous reporting of 
these national- level data.
METHODS
Data
HES7 comprises over 125 million admitted patient, outpa-
tient and emergency department records from hospi-
tals within England’s NHS annually. Inpatient records 
consist of consultant episodes: each episode covers the 
period during which a patient is the responsibility of a 
given physician. A single admission at a given hospital 
may comprise multiple episodes. Episodes were linked 
into admissions and linkage with interhospital transfers 
creates ‘superspells’; we will use the term ‘admission’ 
throughout to refer to superspells. HES provides data 
on in- hospital mortality and is linked to the national 
death register. One primary and up to 19 secondary diag-
noses are coded using ICD-108; one primary and up to 
23 secondary procedures are coded using the UK’s own 
‘OPCS’ coding system. Area- level socioeconomic depriva-
tion status in population- weighted quintiles was linked to 
HES via the patient’s postcode. Coding is completed by 
specialist clinical coders (rather than clinicians) in hospi-
tals from the medical record. Once received centrally the 
data are cleaned to remove duplicates.
We extracted all admissions from HES with the ICD-10 
code M96.6 in the primary diagnosis field (which corre-
sponds to the main problem treated) and discharge dates 
between April 2013 and December 2018.
Outcome measures
We report the primary procedure performed, length of 
stay (LOS) (acute hospital and superspell), final desti-
nation on discharge, in- hospital mortality rate and total 
30- day mortality rate.
We also report the proportion of admissions with a 
procedure, excluding scans via the U chapter of OPCS 
(Diagnostic imaging, testing and rehabilitation), urinary 
catheterisation and auxiliary or minor procedures via the 
X, Y and Z chapters of OPCS (Miscellaneous and subsid-
iary classification of methods and sites of operation).
Statistical analysis
With any coding change, some variation in the uptake 
rate between hospitals is expected. We tried to sepa-
rate the uptake of the new code from any genuine 
underlying change in the number of admissions by 
dividing hospital trusts into ‘early adopters’ and the 
rest. ‘Early adopters’ were defined as those with two or 
more discharges with M96.6 as the primary diagnosis in 
March or April 2015. Simple Poisson regression models 
estimated the linear trend in admissions for each 
group of trusts (‘early adopters’ and ‘other’) and for 
all combined. As a sensitivity analysis the modelling was 
repeated after excluding the first 6 months of the new 
coding period, that is, including only admissions from 
October 2015 onwards.
Patient characteristics were described for the cohort 
from April 2015 including: age, gender, method of 
admission (whether emergency or not), area- level socio-
economic deprivation9 and comorbidity (using the HES 
ICD-10 secondary diagnosis codes). The proportion of 
admissions with a procedure coded, as defined above, 
was noted and the factors associated with a procedure 
derived from a multivariable logistic regression model 
with age, gender, deprivation and comorbidities as 
covariates entered at once with no selection or elimi-
nation. To determine what factors were associated with 
an extended LOS a multivariable logistic regression 
was performed with the same predictors as for having 
a procedure; again, all predictors were retained in 
the model irrespective of their p value. We performed 
the usual diagnostics for logistic regression, including 
checking for collinearity between predictors, good-
ness of fit and residuals. These were satisfactory. In the 
absence of an accepted definition of extended LOS in 
these cases we used the upper quartile boundary (26) to 
define a long LOS. Kaplan- Meier curves were plotted for 
overall survival since admission.
Patient and public involvement
This research was done without patient involvement. As 
an observational study of national- level data it was not 
possible to involve these groups. The suggested next steps 
of designing services to treat these injuries appropriately 
would benefit from patient and public involvement.
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RESULTS
Between 1 April 2013 and 31 December 2018, there were 
24 697 admissions with M96.6 recorded in any diagnosis 
field. After the coding guidance was introduced in March 
2015, there were 22 955 such admissions (84.5% classified 
as emergency) for 16 105 patients. For the 80.3% who had 
M96.6 in the primary diagnosis field, there were 18 888 
admissions (89.5% emergency) for 13 565 patients.
Change in admissions over time
Table 1 gives the number of admissions by year, split by 
whether M96.6 was in the primary or in the secondary 
diagnosis fields.
The subsequent analysis is restricted to admissions with 
M96.6 in the primary diagnosis.
Figure 1 illustrates admissions by month since April 
2014 to December 2018, with elective and emergency 
Table 1 Total numbers of admissions with M96.6 recorded since April 2013
Financial year
(1 April to 31 March)
Numbers of admissions with M96.6 as 
primary diagnosis







2018/2019 to 31 
December 2018
4389 (5852 full- year pro rata) 893 (1191 full- year pro rata)
Total 19 831 4866
Figure 1 Number of admissions by month from April 2013 to December 2018, with elective and emergency admissions shown 
separately.
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admissions shown separately. The rapid rise in admissions 
from April 2015 coincides with the introduction of the 
M96.6 coding guidance.
One hundred sixteen out of 141 hospital trusts using 
the M96.6 code were labelled early adopters. The rate of 
increase (slope) for the non- early adopters was signifi-
cantly higher than that for the early adopters (p=0.001 for 
the interaction term). Taking the early adopters as being 
the ‘true’ underlying trend, there was a 13% annual rise 
in M96.6 admissions between April 2015 and December 
2018 (table 2). Excluding the first 6 months since the 
coding change did not change the rate of increase 
significantly.
Patient characteristics
The majority of admissions were for women (66.4% female, 
33.6% male). Table 3 details patient characteristics.
Operative rate and main procedures performed
Given that the coding advice only came into force in 
March 2015, we now restrict the analysis to the 11 019 
discharges from April 2015 onwards, again with M96.6 as 
the primary diagnosis.
Primary open reduction (W201+W192+W202+W191+ 
W198) was the most common recorded surgical technique 
(21.6%); revision of the prosthesis (W373+W383+W384+W3
74+W403+W393+W404) was performed in 10.4% (the most 
common procedures are listed in online supplemental table 
1).
The overall operative rates were 74.7% in 2015/2016, 
72.1% in 2016/2017 and 74.5% in 2017/2018. For the 
elective admissions, 83.5% had a procedure performed; 
for the emergency admissions, 71.8% had a procedure 
performed, with an overall proportion of 73.0%.
Table 4 gives the operative rate by patient charac-
teristic and the logistic regression results. (See online 
supplemental table 2 for operative rates by age, gender 
and method of admission.) Patients of both sexes aged 
greater than 84 years were significantly less likely to have 
an operation than the youngest age group. Surgery was 
also less likely with increasing socioeconomic depriva-
tion, chronic obstructive pulmonary disease (COPD) and 
neurological disorders. Surgery was more likely in the 
presence of recorded fluid and electrolyte disturbance, 
hypertension and obesity (OR 1.78, 95% CI 1.46 to 2.17).
Length of stay
Median acute hospital LOS was 14 nights (IQR 7–26), 
and median total hospital LOS was 17 nights (IQR 
8–33: online supplemental table 3). Acute hospital LOS 
increased with increasing age and was higher for older 
ages for both sexes and for operative than non- operative 
management at each age group (p<0.001; figures 2 and 3 
and online supplemental tables 3–5).
In multivariable logistic regression, increasing age was 
significantly associated with a longer LOS. A wide variety 
of comorbidities were also associated with a longer LOS, 
but with a smaller effect than that of age (see table 5).
Final destination on discharge
89.3% of identified patients were admitted from their 
usual residence and 74.9% went back there afterwards: 
8.9% went to a care home; 5.3% were discharged to a 
temporary residence; 4.3% died in hospital; and 3.6% 
went to another hospital but for which no HES record 
could be linked.
The total 30- day mortality rate was 3.3% for the 
period 1 April 2015 to 30 June 2018 (deaths via linkage 
to the national death registry were available up to dates 
including 31 July 2018).
Figure 4 shows Kaplan- Meier survival curves for non- 
operative versus operative cases. See online supplemental 
figures 1 and 2 for Kaplan- Meier survival curves by sex 
and age range, respectively.
DISCUSSION
This study sought to establish the burden of peripros-
thetic fractures on the healthcare system in the UK and 
identify any factors associated with differences in treat-
ment or outcome. The number of patients admitted 
to hospital in England with periprosthetic fractures is 
currently around 450 per month. The overall number of 
periprosthetic fractures as coded by M96.6 is increasing 
by approximately 13% each year. Periprosthetic frac-
tures are associated with a relatively prolonged LOS and 
increased dependency on discharge, with 25% unable to 
return directly to their normal residence. Seventy- three 
per cent of people admitted with a periprosthetic fracture 
received an operation. Non- operative management was 
more common in those with comorbidities, increasing 
age and COPD. Mortality was low at 4.3% for in- hospital 
Table 2 Poisson regression showing annual increase in use of M96.6 diagnosis code nationally and split by whether hospitals 
were early adopters of this code
Set of trusts Relative risk per month 95% CI Relative risk per year 95% CI
All 1.011 1.010 to 1.012 1.14 1.13 to 1.15
Early M96.6 adopters 1.010 1.009 to 1.011 1.13 1.11 to 1.14
Non- early adopters 1.016 1.013 to 1.018 1.21 1.17 to 1.24
All (October 2015
onwards only)
1.009 1.008 to 1.010 1.11 1.10 to 1.13
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and 3.3% for total 30- day mortality; for proximal femoral 
fractures, 30- day mortality from the latest National Hip 
Fracture Database (NHFD) report is higher at 6.1%.3
There are limitations to the data, and we have tried not 
to overinterpret the data we have. We cannot be certain 
how complete and accurate the M96.6 coding is. The 
study relies on accurate data recorded by clinicians and 
then coded by clinical coders in hospitals. The primary 
diagnosis and procedure fields in administrative data are 
known to have high accuracy (>95%),10 though secondary 
diagnoses are subject to some under- recording. There 
will be variation between hospitals as to when the coding 
advice was implemented, which is why we estimated the 
trend in two ways. We have attempted to correct for this 
by analysing ‘early adopters’ separately from the complete 
cohort. Reassuringly, the conclusions are broadly the 
same in terms of absolute numbers and relative rate of 
rise. We did not attempt to distinguish between the sites 
of periprosthetic fractures, and some of these fractures 
will have been following arthroplasty of other joints, and 
fracture fixation, particularly neck of femur fracture.11 
M96.6 is not associated with an anatomical code to specify 
the bone and/or joint involved. It is possible to attempt 
to infer the joint involved by any subsequent operation 
codes, but this method is not guaranteed to be accurate 
and does not provide any information regarding the 
site of injury of those who were treated non- operatively 
(approximately 27% of all cases). Nonetheless, despite 
these limitations, we are confident that the increasing 
trend among older people with joint implants accurately 
reflects the everyday clinical situation.
HES data only provide in- hospital mortality, but we 
were able to use the established linkage to the national 
death registry for deaths up to the end of July 2018. 
More importantly, there are no direct data on functional 
outcomes.12 Such additional data would be invaluable to 
allow clinicians and patients to discuss the most appro-
priate management.
This is the first study using the specific clinical code 
M96.6. This was introduced in March 2015, and although 
figure 1 shows a dramatic increase when the coding 
advice was introduced, we are confident that there is a 
significant increasing underlying trend in patients with 
periprosthetic fractures. There have been few studies 
that have examined the periprosthetic patient popula-
tion from a multidisciplinary perspective. There are no 
studies examining risk assessment for these patients with 
the exception of a small retrospective analysis, 39 patients 
with distal femoral fractures from Cleveland, Ohio.13
Our data are in line with previous studies of complica-
tion rates, which have demonstrated periprosthetic frac-
ture rates of 0.1%–18% for hip, 0.3%–5.5% for knee and 
0.5%–3% for shoulder arthroplasties.14
The number of periprosthetic fractures is likely to 
increase, given the ageing population, increased life 
expectancy and increasing numbers of people with joint 
replacements. How these individuals are managed is 
one of the issues that needs to be addressed in order to 
provide optimum care. The likely treatment of these inju-
ries varies depending on the location involved and the 
stability of the implant.






  0–44, female 215 1.1
  0–44, male 468 2.5
  45–64, female 1068 5.7
  45–64, male 792 4.2
  65–84, female 6186 32.8
  65–84, male 3424 18.1
  85+, female 5063 26.8
  85+, male 1672 8.9
Deprivation
  Quintile 1 (least deprived) 4796 25.4
  Quintile 2 4467 23.6
  Quintile 3 4090 21.7
  Quintile 4 3143 16.6
  Quintile 5 (most deprived) 2300 12.2
  Quintile 6 (not known) 92 0.5
Dementia 2634 13.9
Alcohol misuse 625 3.3
Arrhythmias 4130 21.9
Heart failure 1445 7.7
COPD 3337 17.7
Deficiency anaemia 493 2.6
Depression 1231 6.5
Diabetes mellitus 2877 15.2
Fluid disorders 1396 7.4
Hypertension 9208 48.8
Hypothyroidism 1804 9.6
Liver disease 229 1.2









Peripheral vascular disease 520 2.8
Renal disease 2189 11.6
Rheumatological disorders 1619 8.6
Solid tumours 650 3.4
Valvular disease 1091 5.8
COPD, chronic obstructive pulmonary disease.
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The extensive surgery involved in the operative treat-
ment options for these individuals means that these 
patients have to be able to withstand a more significant 
surgical insult than individuals undergoing primary joint 
arthroplasty or those being treated for neck of femur 
fractures. There are also implications for the use of 
hospital resources, with longer operation times, expen-
sive implants and the availability of revision arthroplasty 
specialists in addition to the higher cost of postoperative 
care, including high dependency care.15
In- hospital mortality is significant at around 5%, and 
the rate of new discharge to a care home of around 
15% suggests an increase in dependency of this patient 
group—this represents those who, while admitted from 
their usual residence, were discharged to a different 
location.
Table 4 Operative rate by patient characteristics and multivariable logistic regression results
Factor No operation Operation
Proportion with 
operation (%)
Adjusted OR for 
operation P value
Age 00–44, female 52 163 75.8 1.23 (0.83 to 1.81) 0.299
Age 00–44, male 97 371 79.3 1
Age 45–64, female 203 865 81.0 1.29 (0.91 to 1.83) 0.158
Age 45–64, male 152 640 80.8 1.27 (0.88 to 1.82) 0.206
Age 65–84, female 1576 4610 74.5 0.86 (0.62 to 1.19) 0.371
Age 65–84, male 822 2602 76.0 0.97 (0.69 to 1.34) 0.830
Age 85+, female 1674 3389 66.9 0.6 (0.44 to 0.83) 0.002
Age 85+, male 524 1148 68.7 0.67 (0.48 to 0.94) 0.019
Quintile 1 (least deprived) 1267 3529 73.6 1
Quintile 2 1183 3284 73.5 1.00 (0.91 to 1.10) 0.998
Quintile 3 1082 3008 73.5 0.98 (0.89 to 1.08) 0.742
Quintile 4 882 2261 71.9 0.89 (0.80 to 0.98) 0.025
Quintile 5 (most deprived) 655 1645 71.5 0.84 (0.75 to 0.95) 0.004
Quintile 6 (not known) 31 61 66.3 0.64 (0.41 to 1.01) 0.053
Alcohol misuse 151 474 75.8 0.93 (0.76 to 1.14) 0.484
Arrhythmias 1208 2922 70.8 0.96 (0.89 to 1.05) 0.385
COPD 879 2458 73.7 0.84 (0.74 to 0.96) 0.008
Cancer with metastasis 65 186 74.1 1.02 (0.93 to 1.11) 0.681
Deficiency anaemia 150 343 69.6 0.89 (0.73 to 1.08) 0.229
Dementia 910 1724 65.5 0.88 (0.77 to 1.00) 0.055
Depression 319 912 74.1 1.02 (0.89 to 1.16) 0.830
Diabetes mellitus 777 2100 73.0 0.98 (0.89 to 1.07) 0.613
Fluid disorders 340 1056 75.6 1.31 (1.15 to 1.49) <0.001
Heart failure 466 979 67.8 1.13 (1.06 to 1.21) 0.0004
Hypertension 2424 6784 73.7 1.07 (0.95 to 1.19) 0.264
Hypothyroidism 483 1321 73.2 0.98 (0.71 to 1.35) 0.907
Liver disease 56 173 75.5 1.03 (0.75 to 1.42) 0.868
Obesity 125 659 84.1 1.78 (1.46 to 2.17) <0.001
Other neurological conditions 362 842 69.9 0.80 (0.70 to 0.91) 0.001
Peripheral vascular disease 143 377 72.5 0.87 (0.63 to 1.21) 0.401
Paraplegia 54 126 70.0 1.28 (0.92 to 1.79) 0.145
Pulmonary circulatory disorders 49 155 76.0 1.00 (0.82 to 1.23) 0.974
Renal disease 637 1552 70.9 0.98 (0.88 to 1.09) 0.695
Rheumatological disorders 455 1164 71.9 0.90 (0.80 to 1.01) 0.065
Solid tumours 182 468 72.0 0.96 (0.79 to 1.17) 0.699
Valvular disease 297 794 72.8 1.11 (0.96 to 1.28) 0.161
COPD, chronic obstructive pulmonary disease.
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For patients presenting with hip fracture, surgical 
management is almost always viewed as gold standard 
care for pain relief and to restore mobility where possible. 
Early surgery is important to allow the patient to sit up, 
thereby reducing risk of respiratory problems, malnutri-
tion and difficulty in toileting. This may be different in 
periprosthetic fractures, particularly those around the 
knee, as patients may be able to tolerate sitting up and 
pain may be controlled by immobilising the fracture in a 
cast or brace.
Some patients with frailty do not have the physiological 
reserve to survive major surgery, and this will influence 
decisions between non- operative management, fixation 
and major revision surgery.
For all patients with frailty, either cognitive or physical, 
the decision regarding surgery should be made with the 
individual and the multidisciplinary team and in some 
cases may be viewed as a palliative procedure to manage 
pain.
Notwithstanding the limitations of our analysis, peri-
prosthetic fractures are likely to create an increasing 
burden to patients, clinicians and the wider health and 
social care services. At current rates, the average UK trust 
will admit around one patient with a periprosthetic frac-
ture each week. If the current trend of a 13% annual 
increase continues, this will rise to around two patients 
per week in 5 or 6 years’ time, equating to around 700 
extra bed- days per trust per year, alongside an increase 
in required operating theatre capacity. These patients 
are often complex, both surgically and medically, and 
hospitals may wish to consider whether a specialist local 
or regional service is provided to ensure optimal decision- 
making and management. The costs associated with 
treating periprosthetic fractures often outstrip reimburse-
ment from funders, and so any such service will need to 
be designed in conjunction with funders to ensure it is 
financially viable.16
Data collection and accurate reporting are going to be 
needed to identify all of the cases, and an add- on to the 
NJR is required for complete data capture. If a compar-
ison with proximal femoral fracture is made, the NHS is 
probably where it was with hip fracture care around 15 
years ago as far as the care of periprosthetic fractures is 
concerned. The great improvement in hip fracture care 
ran in parallel with the emergence of ‘orthogeriatrics’ 
as a definite entity. Periprosthetic fractures will need the 
Figure 2 Acute hospital length of stay (LOS) by age and gender.
Figure 3 Acute hospital length of stay (LOS) by operative 
management.
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same level of multidisciplinary input that is adequately 
funded and using all the experience gained with the hip 
fracture population.
Will individual units be able to cope with demand 
or will there be regional specialisation? The resources 
needed will not be limited to orthopaedic surgery, 
where there will need to be enough adequately trained 
arthroplasty revision surgeons, but will include periop-
erative medicine, orthogeriatric input, high dependency 
care, nursing, physiotherapy and care home provision. 
Perhaps, dedicated units that deal with hip fractures and 
periprosthetic fractures will be the model of care for the 
future, with expertise and training opportunities concen-
trated in purpose- built units.
The coding change made in 2015 to make the NHS 
ICD-10 compliant has made the identification of peri-
prosthetic fractures easier. There already appears to be 
an increase of 13% per year in these cases. This requires 
Table 5 Factors associated with a long LOS (≥26 nights)
Factor OR (95% CI) P value
Age 00–44, female 0.66 (0.21 to 2.12) 0.489
Age 00–44, male 1
Age 45–64, female 4.41 (1.77 to 10.95) 0.001
Age 45–64, male 3.97 (1.58 to 9.95) 0.003
Age 65–84, female 11.01 (4.52 to 26.86) <0.001
Age 65–84, male 9.95 (4.07 to 24.32) <0.001
Age 85+, female 17.93 (7.35 to 43.74) <0.001
Age 85+, male 17.00 (6.93 to 41.66) <0.001
Quintile 1 (least deprived) 1
Quintile 2 1.03 (0.93 to 1.13) 0.603
Quintile 3 1.02 (0.92 to 1.13) 0.689
Quintile 4 1.09 (0.98 to 1.22) 0.115
Quintile 5 (most deprived) 1.15 (1.02 to 1.30) 0.027
Quintile 6 (not known) 0.88 (0.50 to 1.53) 0.642
Alcohol misuse 1.14 (0.92 to 1.42) 0.221
Arrhythmias 1.27 (1.17 to 1.38) <0.001
COPD 1.32 (1.17 to 1.50) <0.001
Cancer with metastasis 1.10 (1.00 to 1.20) 0.039
Deficiency anaemia 1.44 (1.18 to 1.74) 0.003
Dementia 1.43 (1.26 to 1.63) <0.001
Depression 1.10 (0.96 to 1.27) 0.187
Diabetes mellitus 1.19 (1.09 to 1.31) 0.0002
Fluid disorders 2.29 (2.04 to 2.56) <0.001
Heart failure 1.03 (0.96 to 1.10) 0.493
Hypertension 1.00 (0.89 to 1.12) 0.949
Hypothyroidism 2.08 (1.54 to 2.81) <0.001
Liver disease 0.83 (0.60 to 1.15) 0.270
Obesity 1.25 (1.05 to 1.48) 0.012
Other neurological conditions 1.47 (1.28 to 1.69) <0.001
Peripheral vascular disease 2.12 (1.53 to 2.92) <0.001
Paraplegia 1.73 (1.29 to 2.32) 0.0003
Pulmonary circulatory disorders 1.05 (0.86 to 1.28) 0.652
Renal disease 1.20 (1.08 to 1.33) 0.0004
Rheumatological disorders 1.17 (1.04 to 1.32) 0.012
Solid tumours 1.68 (1.39 to 2.04) <0.001
Valvular disease 1.30 (1.13 to 1.49) 0.0002
COPD, chronic obstructive pulmonary disease; LOS, length of stay.
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planning for future service provision at local and national 
levels. This may be facilitated by prospective data collec-
tion using a system similar to the NJR or NHFD.
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